Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for OptimizeRx Corp. (OPRX : NSDQ)
 
 • Company Description   
OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.

Number of Employees: 57

 
 • Price / Volume Information   
Yesterday's Closing Price: $41.97 Daily Weekly Monthly
20 Day Moving Average: 271,042 shares
Shares Outstanding: 17.77 (millions)
Market Capitalization: $745.79 (millions)
Beta: 0.55
52 Week High: $99.18
52 Week Low: $39.06
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -30.62% -25.44%
12 Week -56.60% -54.55%
Year To Date -32.43% -26.77%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
400 WATER STREET SUITE 200
-
ROCHESTER,MI 48307
USA
ph: 248-651-6568
fax: 248-453-5529
oprx@cma.team http://www.optimizerx.com
 
 • General Corporate Information   
Officers
William Febbo - Chief Executive Officer; Principal Executive Offic
Douglas P. Baker - Chief Financial Officer; Principal Financial Offic
James Lang - Director
Gus D. Halas - Director
Patrick Spangler - Director

Peer Information
OptimizeRx Corp. (ATEA)
OptimizeRx Corp. (BITS.)
OptimizeRx Corp. (DCTM)
OptimizeRx Corp. (DLVAZ)
OptimizeRx Corp. (DOCC)
OptimizeRx Corp. (NEON)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: COMP-SOFTWARE
Sector: Computer and Technology
CUSIP: 68401U204
SIC: 7389
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/23/22
Share - Related Items
Shares Outstanding: 17.77
Most Recent Split Date: 5.00 (0.33:1)
Beta: 0.55
Market Capitalization: $745.79 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.43 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/23/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 96.85
Trailing 12 Months: 349.75
PEG Ratio: -
Price Ratios
Price/Book: 5.83
Price/Cash Flow: 320.26
Price / Sales: 12.99
EPS Growth
vs. Year Ago Period: 100.00%
vs. Previous Quarter: -100.00%
Sales Growth
vs. Year Ago Period: 53.29%
vs. Previous Quarter: 18.34%
ROE
12/31/21 - -
09/30/21 - 2.03
06/30/21 - 2.26
ROA
12/31/21 - -
09/30/21 - 1.89
06/30/21 - 2.07
Current Ratio
12/31/21 - -
09/30/21 - 14.31
06/30/21 - 15.75
Quick Ratio
12/31/21 - -
09/30/21 - 14.31
06/30/21 - 15.75
Operating Margin
12/31/21 - -
09/30/21 - 3.75
06/30/21 - 3.74
Net Margin
12/31/21 - -
09/30/21 - 4.16
06/30/21 - 3.98
Pre-Tax Margin
12/31/21 - -
09/30/21 - 1.94
06/30/21 - 1.52
Book Value
12/31/21 - -
09/30/21 - 7.20
06/30/21 - 7.08
Inventory Turnover
12/31/21 - -
09/30/21 - -
06/30/21 - -
Debt-to-Equity
12/31/21 - -
09/30/21 - 0.00
06/30/21 - 0.00
Debt-to-Capital
12/31/21 - -
09/30/21 - 0.00
06/30/21 - 0.00
 

Powered by Zacks Investment Research ©